Form 4 for DMRA Damora Therapeutics, Inc.
Accepted 2025-01-07 00:00:00 ET · period of report 2025-01-03 · accession 0000950170-25-002811 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-07 | 2025-01-03 | DMRA | Schambye Hans T. | CEO, Dir | M - OptEx | — | +2,640 | 4,738 | +126% | — |
| D | 2025-01-07 | 2025-01-03 | DMRA | Schambye Hans T. | CEO, Dir | S - Sale+OE | $5.60 | -1,341 | 3,397 | -28% | -$7,510 |
| D | 2025-01-07 | 2025-01-03 | DMRA | Schambye Hans T. | CEO, Dir | A - Grant | $0.00 | +16.4K | 16.4K | New | $0 |
| D | 2025-01-07 | 2025-01-03 | DMRA | Schambye Hans T. | CEO, Dir | M - OptEx | $0.00 | -2,640 | 5,360 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-03 | M | A | 2,640 | — | 4,738 | D | — | — | (F1) Each restricted stock unit ("RSU") represents the right to receive, at settlement, one share of common stock of the Issuer. This transaction represents the settlement of RSUs in shares of common stock on their scheduled vesting date. |
| 2 | Common | Common Stock | 2025-01-03 | S | D | 1,341 | $5.60 | 3,397 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2025-01-03 | A | A | 16,400 | $0.00 | 16,400 | D | $5.70 · — to 2035-01-03 | 16,400 Common Stock | (F4) 25% of the shares subject to such option will vest and become exercisable on January 3, 2026 and the remainder of the shares vest in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date. |
| 4 | Derivative | Restricted Stock Units | 2025-01-03 | M | D | 2,640 | $0.00 | 5,360 | D | — · — to — | 2,640 Common Stock | (F1) Each restricted stock unit ("RSU") represents the right to receive, at settlement, one share of common stock of the Issuer. This transaction represents the settlement of RSUs in shares of common stock on their scheduled vesting date. (F3) This award was granted on January 3, 2024. One-third of the RSUs subject to the award vested on January 3, 2025 and one-sixth of the RSUs subject to the award award will vest ratably every six months thereafter, assuming continued employment through the applicable vesting date. |